Treace Medical Concepts, Inc. Increase (Decrease) in Other Operating Liabilities
Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Other Operating Liabilities of -$119.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-02-27
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was -$616.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was -$575.00K, a 179.86% decline year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-12-31 was -$36.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-09-30 was $720.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$119.00K, a 103.87% decline from fiscal 2022.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $3.08M.
- Treace Medical Concepts, Inc. increase (decrease) in other operating liabilities for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.19M derived: sum of 2 quarters · filed 2024-02-27 | -$119.00K 10-K · filed 2024-02-27 | |
| 2023-09-30 | -$575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $497.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $1.07M 10-Q · filed 2023-08-09 | |||
| 2022-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $684.00K derived: sum of 2 quarters · filed 2024-02-27 | $3.08M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.11M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $2.39M 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |